Who Supplies Empagliflozin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Empagliflozin exports, with 170+ registered manufacturers shipping to buyers across 75+ countries — yet a handful of companies dominate the shipments. LAWRENCE WALTER holds the largest share at 12.0% (export value: $807.6K). Close behind, HEXA HEALTH CARE PRIVATE LIMITED (10.1%, $675.4K). SAVA HEALTHCARE LIMITED (8.4%, $566.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Empagliflozin? Top Manufacturers & Their Buyers
Flow of Empagliflozin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Empagliflozin Supplier Network — Key Market Intelligence
The Empagliflozin export market from India is led by LAWRENCE WALTER, which alone commands a 12.0% share, shipping $807.6K worth of product across 947 shipments. The second-largest exporter, HEXA HEALTH CARE PRIVATE LIMITED, contributes $675.4K (10.1%) to the overall market. Combined, the top two suppliers alone account for 22.1% of all Empagliflozin exports, indicating a relatively concentrated supply base.
Across all 170 tracked manufacturers, the total Empagliflozin export value stands at $6.7M from 3.5K shipments. The market average shipment value is $1.9K. The single largest buyer relationship in terms of trade value is BPOST INTERNATIONAL, receiving $597.1K worth of product.
The combined buyer network spans 14 named purchasing companies, including BPOST INTERNATIONAL, BPOST INTERNATIONAL EMC, TRANS SPED AG - SMI, REGENCY PHARMA LIMITED, REGENCY PHARMA LTD and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1LAWRENCE WALTER
LAWRENCE WALTER is the first-largest Empagliflozin exporter from India, with a market share of 12.0% and a total export value of $807.6K across 947 shipments. Their average shipment value of $853 is below the market average of $1.9K, reflecting a high-volume, competitive pricing strategy.
LAWRENCE WALTER serves 4 named buyers in our database. BPOST INTERNATIONAL is the dominant customer, accounting for 73.9% of this supplier's tracked business. Top customers include:
• BPOST INTERNATIONAL — $597.1K across 700 shipments (73.9% of this supplier's total exports)
• BPOST INTERNATIONAL EMC — $105.1K across 123 shipments (13.0% of this supplier's total exports)
• BPOST INTERNATIONAL — $82.2K across 96 shipments (10.2% of this supplier's total exports)
• TRANS SPED AG - SMI — $23.2K across 27 shipments (2.9% of this supplier's total exports)
Key Insight: LAWRENCE WALTER operates with high shipment frequency (947 shipments) at a per-shipment value of $853, indicating a broad distribution network with many smaller, regular orders.
2HEXA HEALTH CARE PRIVATE LIMITED
HEXA HEALTH CARE PRIVATE LIMITED is the second-largest Empagliflozin exporter from India, with a market share of 10.1% and a total export value of $675.4K across 113 shipments. Their average shipment value of $6.0K is above the market average of $1.9K, suggesting premium or bulk contract pricing.
HEXA HEALTH CARE PRIVATE LIMITED serves 2 named buyers in our database. REGENCY PHARMA LIMITED is the dominant customer, accounting for 50.8% of this supplier's tracked business. Top customers include:
• REGENCY PHARMA LIMITED — $343.2K across 57 shipments (50.8% of this supplier's total exports)
• REGENCY PHARMA LTD — $332.2K across 56 shipments (49.2% of this supplier's total exports)
Key Insight: HEXA HEALTH CARE PRIVATE LIMITED's per-shipment value of $6.0K is 214% above the market average of $1.9K, consistent with large-order contracts or value-added formulations.
3SAVA HEALTHCARE LIMITED
SAVA HEALTHCARE LIMITED is the third-largest Empagliflozin exporter from India, with a market share of 8.4% and a total export value of $566.8K across 495 shipments. Their average shipment value of $1.1K is below the market average of $1.9K, reflecting a high-volume, competitive pricing strategy.
SAVA HEALTHCARE LIMITED serves 2 named buyers in our database. REGENCY PHARMA LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• REGENCY PHARMA LIMITED — $566.7K across 495 shipments (100.0% of this supplier's total exports)
• WAREHOUSE NO.1 BPML — $78 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SAVA HEALTHCARE LIMITED operates with high shipment frequency (495 shipments) at a per-shipment value of $1.1K, indicating a broad distribution network with many smaller, regular orders.
4BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED
BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED is the fourth-largest Empagliflozin exporter from India, with a market share of 8.2% and a total export value of $547.9K across 28 shipments. Their average shipment value of $19.6K is above the market average of $1.9K, suggesting premium or bulk contract pricing.
BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CITI BANK N.A., COLOMBO — $154.4K across 8 shipments (28.2% of this supplier's total exports)
• HOTTON NATIONAL BANK PLC — $119.9K across 6 shipments (21.9% of this supplier's total exports)
• CITI BANK N.A., COLOMBO — $109.1K across 6 shipments (19.9% of this supplier's total exports)
• HATTON NATIONAL BANK PLC — $82.7K across 4 shipments (15.1% of this supplier's total exports)
• CITI BANK NA — $81.8K across 4 shipments (14.9% of this supplier's total exports)
Key Insight: BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED's per-shipment value of $19.6K is 929% above the market average of $1.9K, consistent with large-order contracts or value-added formulations.
5PLEASANT EXPORTS
PLEASANT EXPORTS is the fifth-largest Empagliflozin exporter from India, with a market share of 3.6% and a total export value of $243.3K across 128 shipments. Their average shipment value of $1.9K is below the market average of $1.9K, reflecting a high-volume, competitive pricing strategy.
PLEASANT EXPORTS serves 3 named buyers in our database. ZAPATERO INTERNATIONAL LTD is the dominant customer, accounting for 74.7% of this supplier's tracked business. Top customers include:
• ZAPATERO INTERNATIONAL LTD — $181.8K across 96 shipments (74.7% of this supplier's total exports)
• ZAPATERO INTERNATIONAL LTD — $61.4K across 32 shipments (25.2% of this supplier's total exports)
• THE ESSES PHARMACY ( — $132 across 0 shipments (0.1% of this supplier's total exports)
Key Insight: PLEASANT EXPORTS operates with high shipment frequency (128 shipments) at a per-shipment value of $1.9K, indicating a broad distribution network with many smaller, regular orders.
6SCOTT EDIL PHARMACIA LIMITED
SCOTT EDIL PHARMACIA LIMITED is the fifth-largest Empagliflozin exporter from India, with a market share of 2.7% and a total export value of $178.6K across 12 shipments. Their average shipment value of $14.9K is above the market average of $1.9K, suggesting premium or bulk contract pricing.
SCOTT EDIL PHARMACIA LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $88.6K across 6 shipments (49.6% of this supplier's total exports)
• ALKURAIMI ISLAMIC BA — $53.3K across 4 shipments (29.8% of this supplier's total exports)
• TO THE ORDER OF — $31.6K across 2 shipments (17.7% of this supplier's total exports)
• SAMA SCIENTIFIC BURE — $5.1K across 0 shipments (2.9% of this supplier's total exports)
Key Insight: SCOTT EDIL PHARMACIA LIMITED's per-shipment value of $14.9K is 683% above the market average of $1.9K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Empagliflozin Flows
Once Empagliflozin leaves the manufacturing plants of companies like LAWRENCE WALTER and HEXA HEALTH CARE PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $6.7M. Mauritius absorbs the largest share at 24.7% ($1.7M), followed by Belgium (12.1%) and Singapore (11.4%).
In Mauritius — the top destination — named importers include REGENCY PHARMA LIMITED, REGENCY PHARMA LTD, ZAPATERO INTERNATIONAL LTD. In Belgium, key buyers are BPOST INTERNATIONAL, BPOST INTERNATIONAL EMC.
This geographic spread reflects Empagliflozin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Empagliflozin Go? Top Importing Countries & Their Buyers
Trade flow of Empagliflozin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Mauritius
Mauritius ranks as the first-largest destination for Empagliflozin imports from India, with a total trade value of $1.7M across 788 shipments — representing a 24.7% share of all Empagliflozin exports. The average shipment value of $2.1K is above the global average of $1.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Empagliflozin importers in Mauritius: REGENCY PHARMA LIMITED is the largest buyer, accounting for 61.0% ($1.0M) of this market's total imports.
• REGENCY PHARMA LIMITED — $1.0M (61.0% of Mauritius's total)
• REGENCY PHARMA LTD — $338.7K (20.5% of Mauritius's total)
• ZAPATERO INTERNATIONAL LTD — $193.1K (11.7% of Mauritius's total)
Key Insight: Mauritius's per-shipment average of $2.1K (10% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mauritius is a key market for Empagliflozin imports from India.
2Belgium
Belgium ranks as the second-largest destination for Empagliflozin imports from India, with a total trade value of $812.0K across 900 shipments — representing a 12.1% share of all Empagliflozin exports. The average shipment value of $902 is below the global average of $1.9K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Empagliflozin importers in Belgium: BPOST INTERNATIONAL is the largest buyer, accounting for 85.8% ($696.9K) of this market's total imports.
• BPOST INTERNATIONAL — $696.9K (85.8% of Belgium's total)
• BPOST INTERNATIONAL EMC — $115.1K (14.2% of Belgium's total)
Key Insight: Belgium receives frequent, smaller shipments of Empagliflozin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Belgium is a key market for Empagliflozin imports from India.
3Singapore
Singapore ranks as the third-largest destination for Empagliflozin imports from India, with a total trade value of $766.4K across 55 shipments — representing a 11.4% share of all Empagliflozin exports. The average shipment value of $13.9K is above the global average of $1.9K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Empagliflozin importers in Singapore: VERONA PHARMACY PTE LIMITED- is the largest buyer, accounting for 22.2% ($170.0K) of this market's total imports.
• VERONA PHARMACY PTE LIMITED- — $170.0K (22.2% of Singapore's total)
• SUCCESS INTER LINK PTE LTD — $109.6K (14.3% of Singapore's total)
• BY THE ORDERING OF — $84.9K (11.1% of Singapore's total)
Key Insight: Singapore's per-shipment average of $13.9K (633% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Singapore is a key market for Empagliflozin imports from India.
4United Arab Emirates
United Arab Emirates ranks as the fourth-largest destination for Empagliflozin imports from India, with a total trade value of $568.6K across 49 shipments — representing a 8.5% share of all Empagliflozin exports. The average shipment value of $11.6K is above the global average of $1.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Empagliflozin importers in United Arab Emirates: DAWAA DRUG STORE LLC is the largest buyer, accounting for 14.7% ($83.4K) of this market's total imports.
• DAWAA DRUG STORE LLC — $83.4K (14.7% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $11.6K (510% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Empagliflozin imports from India.
5Sri Lanka
Sri Lanka ranks as the fifth-largest destination for Empagliflozin imports from India, with a total trade value of $548.0K across 18 shipments — representing a 8.2% share of all Empagliflozin exports. The average shipment value of $30.4K is above the global average of $1.9K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Empagliflozin importers in Sri Lanka: CITI BANK N.A., COLOMBO is the largest buyer, accounting for 28.2% ($154.4K) of this market's total imports.
• CITI BANK N.A., COLOMBO — $154.4K (28.2% of Sri Lanka's total)
• HOTTON NATIONAL BANK PLC — $119.9K (21.9% of Sri Lanka's total)
• CITI BANK N.A. COLOMBO — $109.1K (19.9% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $30.4K (1501% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Empagliflozin imports from India.
People Also Ask — Empagliflozin Supplier & Trade Network
Who are the top suppliers of Empagliflozin from India?+
Which companies buy Empagliflozin from Indian manufacturers?+
Where does Empagliflozin exported from India go?+
What is the market share of the top Empagliflozin supplier from India?+
What is the average shipment value for Empagliflozin exports from India?+
Is Empagliflozin manufactured in India and exported globally?+
Which country imports the most Empagliflozin from India?+
Who are the buyers of Empagliflozin in Belgium?+
How concentrated is the Empagliflozin supplier market in India?+
How do I find verified buyers for Empagliflozin in specific countries?+
Empagliflozin Trade Network — Key Takeaways
- 1LAWRENCE WALTER is India's dominant Empagliflozin exporter with a 12.0% market share and $807.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 170 suppliers collectively account for 45.0% of all tracked Empagliflozin exports, with a combined trade value of $6.7M.
- 3Mauritius is the largest destination market, absorbing 24.7% of India's Empagliflozin exports ($1.7M). Belgium (12.1%) and Singapore (11.4%) follow.
- 4With 3.5K total shipments averaging $1.9K each, the Empagliflozin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BPOST INTERNATIONAL, BPOST INTERNATIONAL EMC, REGENCY PHARMA LIMITED, REGENCY PHARMA LTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 75 countries
Network value: $6.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Empagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Empagliflozin.
- 2.Flow Mapping: 170 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,528 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 75 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,528 Verified Shipments
170 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists